Boothbay Fund Management’s Merck MRK Stock Holding History

Boothbay Fund Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,100	Closed	-$4.01M	–	2379
2022 Q4	$4.01M	Buy	36,100 +31,000	+608%	+$3.17M	0.09%	309
2022 Q3	$439K	Sell	5,100 -122,000	-96%	-$10.9M	0.01%	1296
2022 Q2	$11.6M	Buy	127,100 +116,800	+1,134%	+$10.4M	0.31%	36
2022 Q1	$845K	Buy	+10,300	New	+$812K	0.02%	1006
2021 Q4	–	Sell	-585,800	Closed	-$44M	–	2097
2021 Q3	$44M	Buy	+585,800	New	+$44.6M	1.22%	3
2019 Q4	–	Sell	-201	Closed	-$1.62M	–	935
2019 Q3	$1.62M	Buy	+201	New	+$16.1K	0.15%	191
2018 Q3	–	Sell	-330	Closed	-$1.91M	–	889
2018 Q2	$1.91M	Buy	+330	New	+$18.6K	0.17%	105

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boothbay Fund Management's MRK Position: Q1 2026 in Review

Boothbay Fund Management increased its Merck (MRK) stake by 347% in Q1 2026, buying an estimated $2.26M and bringing the position to 25,244 shares worth $3.04M. The position accounts for 0.04% of the portfolio, ranked #470.

Boothbay Fund Management first reported a position in MRK in Q1 2015 and has held it in 32 quarters since. The position peaked at $23.5M in Q1 2023. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Boothbay Fund Management held 25,244 shares of Merck worth $3.04M as of Q1 2026.
Boothbay Fund Management bought 19,598 Merck shares in Q1 2026, an estimated $2.26M.
Merck made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #470 holding.
Boothbay Fund Management first reported a position in Merck in Q1 2015 and has held it in 32 quarters since.
Boothbay Fund Management's Merck position peaked at $23.5M in Q1 2023.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.